Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration
This study has been completed.
Study NCT00000563   Information provided by National Heart, Lung, and Blood Institute (NHLBI)

First Received on October 27, 1999.   Last Updated on April 26, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lung Diseases
Respiratory Distress Syndrome
Additional conditions recognized in this trial
Hyaline Membrane Disease
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
More general conditions related to this trial
Infant, Newborn, Diseases
Infant, Premature, Diseases
Respiration Disorders
Respiratory Tract Diseases
Interventions listed in this trial
dexamethasone
Additional drug interventions recognized in this trial
BB 1101
Dexamethasone 21-phosphate
Dexamethasone acetate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services